Clinical Trials Logo

Healthy clinical trials

View clinical trials related to Healthy.

Filter by:

NCT ID: NCT06433323 Active, not recruiting - Healthy Clinical Trials

Biological Anti-aging Efficacy of a Cosmetic Night Cream

Start date: May 23, 2024
Phase:
Study type: Observational

In a previous study, the cosmetic night cream RV4983A- LA3365 has proven a great efficacy in reducing the clinical signs of skin aging, as well as a great tolerance. The skin structure and composition greatly evolve over the time, and deciphering the biological mechanisms by which the cosmetic night cream RV4983A- LA3365 reduces the signs of skin aging is therefore of great interest to deepen our efficacy evaluation and knowledge on skin aging biology.

NCT ID: NCT06432504 Recruiting - Healthy Clinical Trials

Variation in the Impact of Coffee on the Metabolic Rate

Start date: March 6, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to explore variation in the impact of coffee on metabolic rate. The investigators plan to recruit healthy participants, half male and half female.

NCT ID: NCT06431932 Not yet recruiting - Healthy Clinical Trials

Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity

Start date: June 1, 2024
Phase: Phase 1/Phase 2
Study type: Interventional

The accumulation of senescent cells with age is a central mechanism that contributes to the development of chronic diseases, primarily by driving systemic chronic inflammation. Senolytic compounds such as fisetin can selectively target senescent cells for elimination and reduce multiple age-related pathologies in animal models. We will conduct a clinical trial in healthy volunteers and older patients with multiple chronic diseases. The participants will receive fisetin or placebo for two days, after which they will be examined at regular intervals for up to three months. We will investigate how fisetin is absorbed and metabolized by the body, and whether fisetin is safe. We will also identify methods to best measure the effect of fisetin on chronic inflammation, senescent cells, and general health.

NCT ID: NCT06431399 Recruiting - Healthy Clinical Trials

To Evaluate the Safety, Pharmacokinetic Characteristics and the Effect of Food After Administration of JLP-2004

Start date: April 23, 2024
Phase: Phase 1
Study type: Interventional

To evaluate the safety, pharmacokinetic characteristics and the effect of food after administration of JLP-2004

NCT ID: NCT06431334 Not yet recruiting - Healthy Clinical Trials

Protein Requirements Amongst Male Masters-Level Athletes Following a Cycling Exercise Bout as Determined by the Indicator Amino Acid Oxidation Technique

Start date: May 2024
Phase: N/A
Study type: Interventional

Masters level cyclists are a population above the age of 35 years who frequently participate in prolonged as well as heavy-volume training. Like most endurance-trained athletes, a greater recommended dietary allowance (RDA) for protein of 1.2-1.4 g/kg/bw is suggested. Dietary protein intake is vital for maximizing the benefits of training and ensuring optimal recovery. Dietary recommendations traditionally have been determined through nitrogen balance techniques, however, recent research indicates how this method is potentially underestimating protein requirements. Therefore, there is a need to reassess current dietary recommendations in order to meet the demands of physical activity for highly active populations. Recent efforts to understand protein requirements during rest and following exercise have been completed using the indicator amino acid technique (IAAO). This non-invasive method is reported to provide a robust measure of protein requirements. However, there is limited work in older (≥60 years) active populations. The purpose of this study is to measure the protein requirements in master cyclists, following an endurance training session, using the non-invasive IAAO technique.

NCT ID: NCT06429566 Active, not recruiting - Healthy Clinical Trials

Safety and Efficacy Study of GB001 Recombinant Peptide Spray in Subjects With Mild Recurrent Aphthous Ulcers

Start date: July 18, 2023
Phase: Phase 2
Study type: Interventional

This trial is conducted in China. The purpose is to evaluate the efficacy, Pharmacokinetics (PK) profile, immunogenicity and safety of GB001 recombinant peptide spray in adults with mild recurrent aphthous ulcer.

NCT ID: NCT06429410 Not yet recruiting - Healthy Clinical Trials

Effects of Milk Powder Intervention on Body Composition and Physical Performance in Middle-aged and Older Adults

Start date: May 2024
Phase: N/A
Study type: Interventional

This study aims to conduct a 24-week intervention involving formula milk powder for middle-aged and elderly individuals, assessing its impact on body composition and physical performance in comparison to interventions using regular milk powder and individuals without intervention.

NCT ID: NCT06429137 Not yet recruiting - Healthy Clinical Trials

A Study in Healthy Men to Test How Well Different Doses of BI 3731579 Are Tolerated

Start date: June 26, 2024
Phase: Phase 1
Study type: Interventional

The main objectives of this trial are to investigate safety, tolerability and pharmacokinetics (PK) of BI 3731579 in healthy male subjects.

NCT ID: NCT06426498 Recruiting - Healthy Clinical Trials

tFUS Induced Transient Scotoma for Individual Dosing

Start date: June 20, 2024
Phase: N/A
Study type: Interventional

The purposes of this research study is to: 1. Develop a technique of transcranial Focused Ultrasound Stimulation (tFUS) where meaningful effects on the brain can be easily measured. 2. Use this technique to measure threshold for effective tFUS in individuals. 3. Determine whether disruption of conscious visual detection, versus non-conscious visually-guided behavior have different thresholds for disruption with tFUS.

NCT ID: NCT06425861 Recruiting - Healthy Clinical Trials

A First in Human Trial Evaluating THB335 in Healthy Participants

Start date: May 2, 2024
Phase: Phase 1
Study type: Interventional

This study is a double blind, randomized, placebo-controlled, Phase 1 study in two parts: single ascending doses and food effect (Part 1) and multiple ascending doses (Part 2).